An update of the recommendations of the spanish neonatology society for the use of paivizumab as prophylaxis for severe infections due to syncytial respiratory virus in high risk infants - Manuel Sánchez Luna; Alejandro Pérez Muñuzuri; José Luis Leante Castellanos; César W. Ruiz Campillo; Ester Sanz López; Isabel Benavente Fernández; María Dolores Sánchez Redondo; Segundo Rite Gracia (Elsevier, 2019)